https://www.selleckchem.com/pr....oducts/Rapamycin.htm
44, 95% confidence interval [CI] 0.36-0.52], p less then 0.001). The effect of DES on TLR was limited in time to the first 2 years in the study with no evidence of a later rebound effect. The reduction in TLR after DES insertion was consistent across subgroups defined by gender, age, diabetes status, renal function, and lesion and stent characteristics. The number needed to treat with DES (vs. BMS) to prevent 1 TLR ranged from 4 to 110 across clinically relevant subgroups. CONCLUSION DES have a time-limited effect on the rate of TLR,